Efficacy of Adding Once-Daily Insulin Glulisine in Japanese Type 2 Diabetes Patients Treated with Insulin Glargine and Sitagliptin

被引:2
作者
Takahara, Mitsuyoshi [1 ]
Shiraiwa, Toshihiko [2 ]
Katakami, Naoto [1 ]
Matsuoka, Taka-aki [1 ]
Shimomura, Iichiro [1 ]
机构
[1] Osaka Univ, Grad Sch Med, Dept Metab Med, Suita, Osaka 5650871, Japan
[2] Shiraiwa Med Clin, Osaka, Japan
关键词
IMPROVES GLYCEMIC CONTROL; BASAL INSULIN; GLUCOSE-TOLERANCE; OXIDATIVE STRESS; CONTROLLED-TRIAL; FASTING GLUCOSE; PLASMA-GLUCOSE; ORAL-THERAPY; FOLLOW-UP; MELLITUS;
D O I
10.1089/dia.2014.0075
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Glucose fluctuation often remains to be corrected under basal-supported oral therapy. We investigated the efficacy of adding once-daily rapid-acting insulin in Japanese diabetes patients treated with basal-supported oral therapy. Subjects and Methods: In this 8-week, parallel-group, randomized, open-label trial, 62 Japanese adults with type 2 diabetes treated with insulin glargine and 50 mg of sitagliptin were randomized into the following two arms: the single-bolus group, in which once-daily insulin glulisine was initiated at a main meal at a fifth (i.e., 20%) the dose of insulin glargine, and the control group, in which the dose of sitagliptin was maximized to 100 mg. The primary end point was the change of glycemic fluctuation assessed with the M-value. Results: Baseline hemoglobin A1c levels, mean blood glucose profiles, and M-value were 7.2 +/- 0.6%, 9.3 +/- 1.7 mmol/L, and 21 +/- 13 units, respectively. At the end of the study, the single-bolus group had a greater reduction of M-value than the control group (P=0.02); the difference was 6.5 units (95% confidence interval, 1.1-11.9 units). The single-bolus group also had a greater reduction of mean blood glucose levels (P=0.01). There were no significant differences in the incidence of hypoglycemia or the weight change between the two groups (P>0.05). Conclusions: Adding once-daily insulin glulisine was more effective in controlling the glycemic fluctuation in Japanese type 2 diabetes patients treated with insulin glargine together with sitagliptin.
引用
收藏
页码:633 / 639
页数:7
相关论文
共 33 条
[1]   Further Improvement in Postprandial Glucose Control With Addition of Exenatide or Sitagliptin to Combination Therapy With Insulin Glargine and Metformin A proof-of-concept study [J].
Arnolds, Sabine ;
Dellweg, Sibylle ;
Clair, Janina ;
Dain, Marie-Paule ;
Nauck, Michael A. ;
Rave, Klaus ;
Kapitza, Christoph .
DIABETES CARE, 2010, 33 (07) :1509-1515
[2]  
Borch-Johnsen K, 1999, LANCET, V354, P617
[3]   Once-daily basal insulin glargine versus thrice-daily prandial insulin lispro in people with type 2 diabetes on oral hypoglycaemic agents (APOLLO): an open randomised controlled trial [J].
Bretzel, Reinhard G. ;
Nuber, Ulrike ;
Landgraf, Wolfgang ;
Owens, David R. ;
Bradley, Clare ;
Linn, Thomas .
LANCET, 2008, 371 (9618) :1073-1084
[4]   Postprandial Blood Glucose Predicts Cardiovascular Events and All-Cause Mortality in Type 2 Diabetes in a 14-Year Follow-Up [J].
Cavalot, Franco ;
Pagliarino, Andrea ;
Valle, Manuela ;
Di Martino, Leonardo ;
Bonomo, Katia ;
Massucco, Paola ;
Anfossi, Giovanni ;
Trovati, Mariella .
DIABETES CARE, 2011, 34 (10) :2237-2243
[5]   Oscillating glucose is more deleterious to endothelial function and oxidative stress than mean glucose in normal and type 2 diabetic patients [J].
Ceriello, Antonio ;
Esposito, Katherine ;
Piconi, Ludovica ;
Ihnat, Michael A. ;
Thorpe, Jessica E. ;
Testa, Roberto ;
Boemi, Massimo ;
Giugliano, Dario .
DIABETES, 2008, 57 (05) :1349-1354
[6]  
Chang Anna, 2009, J Diabetes Sci Technol, V3, P1158
[7]  
Davidson JA, 2013, ETHNIC DIS, V23, P393
[8]   IMPACT OF RACE/ETHNICITY ON THE EFFICACY AND SAFETY OF COMMONLY USED INSULIN REGIMENS: A POST HOC ANALYSIS OF CLINICAL TRIALS IN TYPE 2 DIABETES MELLITUS [J].
Davidson, Jaime A. ;
Lacaya, Lyndon B. ;
Jiang, Honghua ;
Heilmann, Cory R. ;
Scism-Bacon, Jamie L. ;
Gates, Jeffrey R. ;
Jackson, Jeffrey A. .
ENDOCRINE PRACTICE, 2010, 16 (05) :818-828
[9]   Sustained efficacy and reduced hypoglycemia during one year of treatment with vildagliptin added to insulin in patients with type 2 diabetes mellitus [J].
Fonseca, V. ;
Baron, M. ;
Shao, Q. ;
Dejager, S. .
HORMONE AND METABOLIC RESEARCH, 2008, 40 (06) :427-430
[10]   Addition of vildagliptin to insulin improves glycaemic control in type 2 diabetes [J].
Fonseca, V. ;
Schweizer, A. ;
Albrecht, D. ;
Baron, M. A. ;
Chang, I. ;
Dejager, S. .
DIABETOLOGIA, 2007, 50 (06) :1148-1155